NPM1 and acute myeloid leukemia: The study indicated that the frequency of several HLA allelic groups was lower in patients with nucleophosmin mutations (denoted as NPMc+ in association with the cytoplasmic localization of the mutated protein) compared to the normal values as well as to the frequency observed in AML patients with wild-type NPM1 [10].